Showing results (261-270 of 317) with videos related to
Sort By:
Pageof 32
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 31, 2011
A phase I study of sunitinib in combination with FOLFIRI in patients with untreated metastatic colorectal cancerN Starling, F Vázquez-Mazón, D Cunningham, et al.Frontiers in Psychology|October 3, 2024
The influence of positivity and self-efficacy beliefs on family functioning among young adults in Italy and ColombiaRoberto Baiocco, Jessica Pistella, Maryluz Gomez Plata, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2021
Adjuvant Therapy for Stage II Colon Cancer: ASCO Guideline UpdateNancy N Baxter, Erin B Kennedy, Emily Bergsland, et al.The Journal of Allergy and Clinical Immunology|July 25, 2020
Cardiovascular changes during peanut-induced allergic reactions in human subjectsMonica Ruiz-Garcia, Joan Bartra, Olaya Alvarez, et al.Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|June 12, 2019
Periodic focal epileptiform dischargesWilliam O Tatum, Anteneh M Feyissa, Karim ReFaey, et al.JIMD Reports|February 25, 2026
Intrathecal idursulfase-IT in children younger than 3 years with neuronopathic mucopolysaccharidosis II in a single-arm, open-label, phase 2/3 substudy and extensionJoseph Muenzer, Barbara K Burton, Paul Harmatz, et al.American Journal of Respiratory Cell and Molecular Biology|June 6, 2024
Cell Culture Differentiation and Proliferation Conditions Influence the In Vitro Regeneration of the Human Airway EpitheliumElisa Redman, Morgane Fierville, Amélie Cavard, et al.Journal of Inherited Metabolic Disease|September 10, 2024
Evaluation of early treatment with intravenous idursulfase and intrathecal idursulfase-IT on cognitive function in siblings with neuronopathic mucopolysaccharidosis IIJoseph Muenzer, Barbara K Burton, Paul Harmatz, et al.Cancer|February 7, 2014
A phase 2 trial of dacomitinib (PF-00299804), an oral, irreversible pan-HER (human epidermal growth factor receptor) inhibitor, in patients with advanced non-small cell lung cancer after failure of prior chemotherapy and erlotinibKaren L Reckamp, Giuseppe Giaccone, D Ross Camidge, et al.Journal of Neurological Surgery. Part B, Skull Base|July 14, 2022
Skull Base Meningiomas in Patients with Neurofibromatosis Type 2: An International Multicenter Study Evaluating Stereotactic RadiosurgeryHenry Ruiz-Garcia, Daniel M Trifiletti, Nasser Mohammed, et al.Pageof 32